Gujarat Kidney & Super Speciality Latest Share Price (GKSL)
TODAY IN ONE LINE
GKSL is little changed at ₹152.46 — a quiet consolidation day, supported by recent strong earnings.
With a market cap of ₹1,206.3 Cr., it trades at a P/E of 76.09. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Gujarat Kidney & Super Speciality flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 213.0% and Profit up 294.0%
- ●Healthy Operating MarginsOPM is structurally strong at 32.8%
- ●High Promoter HoldingPromoters hold 71.5% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.12x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Expensive ValuationTrading at a high P/E ratio of 65.0x
Latest Gujarat Kidney & Super Speciality News
What changed recently?
Recent events, corporate actions, and announcements.
Gujarat Kidney & Super Speciality Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Gujarat Kidney & Super Speciality Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Gujarat Kidney & Super Speciality Ltd trades at a P/E of 76.09× and P/B of 4.78×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Gujarat Kidney & Super Speciality Ltd technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Gujarat Kidney & Super Speciality Ltd — derived from the latest tape, not yesterday's close.
Gujarat Kidney & Super Speciality Ltd last traded at ₹152.46 with an intraday range of ₹150.16–₹157.44 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹152.46| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 171.11 | +18.65 | +12.23% |
| R3 | 163.83 | +11.37 | +7.46% |
| R2 | 160.63 | +8.17 | +5.36% |
| R1 | 156.55 | +4.09 | +2.68% |
| PIVOT | 153.35 | 0.89 | 0.59% |
| CURRENT | 152.46 | — | — |
| S1 | 149.27 | -3.19 | -2.09% |
| S2 | 146.07 | -6.39 | -4.19% |
| S3 | 141.99 | -10.47 | -6.87% |
| S4 | 134.71 | -17.75 | -11.64% |
GKSL is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹152.54–₹156.74
Trading Inside opening range
Gujarat Kidney & Super Speciality Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Gujarat Kidney & Super Speciality Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Gujarat Kidney & Super Speciality Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,206.3 Cr. and reported EPS of ₹1.97.
| Metric | — | Mar 2026 |
|---|---|---|
| Revenue from Operations | — | 82 |
| Other Income | — | 1 |
| Total Income | — | 83 |
| — | 9 | |
| Gross ProfitDerived | — | 73 |
| Gross Margin %Derived | — | 88.89% |
| — | 46 | |
| EBITDA (Operating Profit)Derived | — | 27 |
| OPM %Derived | — | 32.85% |
| — | 7 | |
| Profit Before Tax (PBT) | — | 21 |
| — | 4 | |
| Effective Tax %Derived | — | 20.83% |
| Total Profit for Period | — | 17 |
| Less: Non-controlling Interests | — | 1 |
| Net Profit (Owner's PAT)Derived | — | 15 |
| Net Profit Margin %Derived | — | 18.90% |
| Earnings Per Share (EPS ₹) | — | 1.97 |
| Diluted Shares Outstanding (Cr) | — | 8 |
| Other Comprehensive Income (Net of Tax) | — | -0 |
| Total Expenses (incl. D&A & Interest) | — | 62 |
| Material Cost % of RevenueDerived | — | 11.11% |
| Employee Cost % of RevenueDerived | — | 16.63% |
| Other Cost % of RevenueDerived | — | 39.41% |
| Interest Coverage (x)Derived | — | 11.84x |
| Period | Mar 2026 | Trend |
|---|---|---|
| Revenue from Operations | 82 | |
| Other Income | 1 | |
| Total Income | 83 | |
9 | ||
| Gross ProfitDerived | 73 | |
| Gross Margin %Derived | 88.89% | |
46 | ||
| EBITDA (Operating Profit)Derived | 27 | |
| OPM %Derived | 32.85% | |
7 | ||
| Profit Before Tax (PBT) | 21 | |
4 | ||
| Effective Tax %Derived | 20.83% | |
| Total Profit for Period | 17 | |
| Less: Non-controlling Interests | 1 | |
| Net Profit (Owner's PAT)Derived | 15 | |
| Net Profit Margin %Derived | 18.90% | |
| Earnings Per Share (EPS ₹) | 1.97 | |
| Diluted Shares Outstanding (Cr) | 8 | |
| Other Comprehensive Income (Net of Tax) | -0 | |
| Total Expenses (incl. D&A & Interest) | 62 | |
| Material Cost % of RevenueDerived | 11.11% | |
| Employee Cost % of RevenueDerived | 16.63% | |
| Other Cost % of RevenueDerived | 39.41% | |
| Interest Coverage (x)Derived | 11.84x |
Gujarat Kidney & Super Speciality segment analysis : revenue and profit mix.
Disclosed business segments at Gujarat Kidney & Super Speciality with their share of revenue and profit, switchable between consolidated and standalone reporting.
Gujarat Kidney & Super Speciality discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Gujarat Kidney & Super Speciality Ltd.
Our AI distills the core fundamental drivers supporting Gujarat Kidney & Super Speciality Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 99 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Gujarat Kidney & Super Speciality Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Gujarat Kidney & Super Speciality Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Gujarat Kidney & Super Speciality Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Gujarat Kidney & Super Speciality Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Gujarat Kidney & Super Speciality Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Gujarat Kidney & Super Speciality Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Gujarat Kidney & Super Speciality Ltd stood at 41.6% of traded volume, against a 20-day average of 47.4%.
Gujarat Kidney & Super Speciality announcements: results, concalls, ratings, M&A.
Filings Gujarat Kidney & Super Speciality sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Gujarat Kidney & Super Speciality files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 42 documents below.
Updates
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding 'Financial results for Quarter ended June 2026'.
Outcome of Board Meeting
Gujarat Kidney And Super Speciality Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Change in Management
Gujarat Kidney And Super Speciality Limited has informed the Exchange about change in Management
Statement of deviation(s) or variation(s) under Reg. 32
Gujarat Kidney And Super Speciality Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Monitoring Agency Report
Monitoring Agency Report for Quarter ended June 2026
Gujarat Kidney & Super Speciality dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Gujarat Kidney & Super Speciality has declared, sequenced by announce and record date.
Gujarat Kidney & Super Speciality corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Gujarat Kidney & Super Speciality Ltd: business, sector, key facts.
What Gujarat Kidney & Super Speciality Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Gujarat Kidney & Super Speciality Ltd is a listed Indian equity, listed as NSE: GKSL, BSE: 544666.
Gujarat Kidney & Super Speciality Ltd
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Gujarat Kidney & Super Speciality Ltd (GKSL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Gujarat Kidney & Super Speciality Ltd (GKSL)?
The current share price of Gujarat Kidney & Super Speciality Ltd (GKSL) is ₹152.46. Today, the stock has declined by ₹0.08 (0.05%), trading in a range of ₹150.16 to ₹157.44. The stock opened at ₹152.54 with a trading volume of 5,74,445 shares.
02Is Gujarat Kidney & Super Speciality Ltd stock a good investment for long-term?
Gujarat Kidney & Super Speciality Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,206.3 Cr., P/E ratio of 76.09, ROE of 11.1%, and ROCE of 14.5%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Gujarat Kidney & Super Speciality Ltd stock?
The 52-week high price of Gujarat Kidney & Super Speciality Ltd (GKSL) is ₹162.22, while the 52-week low is ₹98.36. Currently trading at ₹152.46, the stock is 55% above its 52-week low and 6.02% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Gujarat Kidney & Super Speciality Ltd stock at the current price?
Whether to buy Gujarat Kidney & Super Speciality Ltd stock at ₹152.46 depends on multiple factors. The stock is currently trading with a P/E ratio of 76.09 and P/B ratio of 4.78. Today's performance shows a loss of 0.05%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Gujarat Kidney & Super Speciality Ltd and when is the next dividend?
Gujarat Kidney & Super Speciality Ltd offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹152.46, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Gujarat Kidney & Super Speciality Ltd?
Gujarat Kidney & Super Speciality Ltd's key financial metrics include: P/E Ratio: 76.09, P/B Ratio: 4.78, ROE: 11.1%, ROCE: 14.5%, Dividend Yield: 0%, EPS: ₹1.97, Book Value: ₹32.00, and Debt-to-Equity: 0.12. The company's market cap stands at ₹1,206.3 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Gujarat Kidney & Super Speciality Ltd stock performing today in the market?
Gujarat Kidney & Super Speciality Ltd stock opened at ₹152.54 and is currently trading at ₹152.46, showing a decline of ₹0.08 (0.05%). The intraday high is ₹157.44 and low is ₹150.16. The trading volume stands at 5,74,445 shares, indicating moderate market participation today.
08What is the P/E ratio of Gujarat Kidney & Super Speciality Ltd and what does it indicate?
Gujarat Kidney & Super Speciality Ltd has a Price-to-Earnings (P/E) ratio of 76.09, which means investors are willing to pay 76.09 for every ₹1 of earnings. With an EPS of ₹1.97, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Gujarat Kidney & Super Speciality Ltd (GKSL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.